Meadow Creek Wealth Advisors’s Pfizer PFE Stock Holding History

Meadow Creek Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	11,884 -370	-3%	-$9.68K	0.17%	111
2026 Q1	$344K	Buy	12,254 +156	+1%	+$4.15K	0.22%	93
2025 Q4	$301K	Buy	12,098 +121	+1%	+$3.05K	0.19%	105
2025 Q3	$290K	Sell	11,977 -1,621	-12%	-$40K	0.19%	110
2025 Q2	$330K	Buy	13,598 +34	+0.3%	+$793	0.22%	99
2025 Q1	$344K	Sell	13,564 -520	-4%	-$13.6K	0.26%	87
2024 Q4	$374K	Sell	14,084 -845	-6%	-$22.9K	0.27%	78
2024 Q3	$432K	Buy	14,929 +100	+0.7%	+$2.92K	0.34%	71
2024 Q2	$415K	Hold	14,829	–	–	0.39%	64
2024 Q1	$412K	Buy	14,829 +135	+0.9%	+$3.75K	0.29%	78
2023 Q4	$423K	Buy	+14,694	New	+$444K	0.41%	54
2022 Q3	$645K	Hold	14,741	–	–	0.85%	25
2022 Q2	$773K	Sell	14,741 -2,354	-14%	-$120K	0.95%	18
2022 Q1	$885K	Sell	17,095 -7,581	-31%	-$393K	0.96%	20
2021 Q4	$1.46M	Buy	+24,676	New	+$1.22M	1.37%	8
2019 Q4	$834K	Buy	+22,428	New	+$799K	1.16%	15

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Meadow Creek Wealth Advisors's PFE Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its Pfizer (PFE) stake by 3% in Q2 2026, selling an estimated $9.68K and leaving 11,884 shares worth $286K. The position accounts for 0.17% of the portfolio, ranked #111.

Meadow Creek Wealth Advisors first reported a position in PFE in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.46M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Meadow Creek Wealth Advisors held 11,884 shares of Pfizer worth $286K as of Q2 2026.
Meadow Creek Wealth Advisors sold 370 Pfizer shares in Q2 2026, an estimated $9.68K.
Pfizer made up 0.17% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #111 holding.
Meadow Creek Wealth Advisors first reported a position in Pfizer in Q4 2019 and has held it in 16 quarters since.
Meadow Creek Wealth Advisors's Pfizer position peaked at $1.46M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.